Shares of PolarityTE ( COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on discovering, designing and developing a range of regenerative tissue products and biomaterials, are rising after the company announced results demonstrating that the company's autologous bone product in development, OsteoTE, regenerated complex, hierarchically-organized, corticocancellous bone within critically-sized bone defects in standard preclinical large animal models.
PolarityTE Up 15% After Reporting On Autologous Bone Product
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться